Background: Type 2 diabetes mellitus (T2DM) is a serious public health issue with significantly increasing rates across the world. The genome-wide association studies (GWAS) have previously manifested involved genes that remarkably enhance the risk of T2DM. In this study, the association of common variants with T2DM risk has been identified among Iranian population from Tehran province of Iran. Methods: Here, the association of refSNPs with T2DM risk was examined on peripheral blood samples of 268 individuals including control group and patients with T2DM using the tetra amplification refractory mutation system (ARMS) methods and direct genomic DNA sequencing. Results: Our study demonstrated that SLC30A8 rs13266634 (T/C), CDKAL1 rs10946398 (A/C), TCF7L2 rs7903146 (C/T), KCNQ1 rs2237892 (T/C), and IGF2BP2 rs1470579 (A/C) polymorphisms are significantly associated with type 2 diabetes, but no significant association was identified for FTO rs8050136 and MTNR1B rs10830963 polymorphisms. Conclusion: The prediction of refSNPs is remarkably needed for pharmacogenetics and pharmacogenomic approaches, in which the information would be useful for clinicians to optimize therapeutic strategies and adverse drug reactions in patients with T2DM.
CITATION STYLE
Yazdi, K. V., Kalantar, S. M., Houshmand, M., Rahmanian, M., Manaviat, M. R., Jahani, M. R., … Almasi-Hashiani, A. (2020). Slc30a8, cdkal1, tcf7l2, kcnq1 and igf2bp2 are associated with type 2 diabetes mellitus in iranian patients. Diabetes, Metabolic Syndrome and Obesity, 13, 897–906. https://doi.org/10.2147/DMSO.S225968
Mendeley helps you to discover research relevant for your work.